top of page

Wissenschaftliche Studien zu mRNA

ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine

Vaskulitis

Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy

Bell’s Palsy

The association between COVID-19 vaccination and Bell's palsy

Bell’s Palsy

Left Bell's palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine A case report

Bell’s Palsy

Bilateral Facial Nerve Palsy and COVID-19 Vaccination Causation or Coincidence

Bell’s Palsy

Bell's palsy or an aggressive infiltrating basaloid carcinoma post-mRNA vaccination for COVID-19

Bell’s Palsy

Bell's palsy following COVID-19 vaccination

Bell’s Palsy

Bell's palsy following COVID-19 vaccination with high CSF antibody response

Bell’s Palsy

Bell's palsy and SARS-CoV-2 vaccines—an unfolding story

Bell’s Palsy

Bell's palsy after inactivated COVID-19 vaccination in a patient with history of recurrent Bell's palsy A case report

Bell’s Palsy

Bell's Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine

Bell’s Palsy

Bell’s palsy following COVID-19 vaccination, a case repor

Bell’s Palsy

Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy

Bell’s Palsy

Adverse event reporting and Bell's palsy risk after COVID-19 vaccination

Bell’s Palsy

Unilateral axillary adenopathy induced by COVID-19 vaccine US follow-up evaluation

Axillary Adenopathy

Unilateral axillary adenopathy in the setting of COVID-19 vaccine Follow-up

Axillary Adenopathy

Evolving Bilateral Hypermetabolic Axillary Lymphadenopathy on FDG PET CT Following 2-Dose COVID-19 Vaccination

Axillary Adenopathy

COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram

Axillary Adenopathy

COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan

Axillary Adenopathy

Axillary Adenopathy in Patients with Recent Covid-19 Vaccination A New Diagnostic Dilemma

Axillary Adenopathy

bottom of page